{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:34:35Z","timestamp":1793363675956,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"Abstract<\/jats:title>\n \n Background:<\/jats:title>\n Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disorder in which eosinophils and immunoglobulin E (IgE) are implicated in disease pathogenesis and are potential markers of disease activity.<\/jats:p>\n <\/jats:sec>\n \n Aim and Objective:<\/jats:title>\n To evaluate the association of serum and tissue eosinophils and IgE levels with disease severity in BP.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods:<\/jats:title>\n A prospective observational study was conducted from October 2023 to December 2024 at a tertiary care center in South India. Thirty-five patients with clinically and histopathologically confirmed BP were included, disease severity was assessed using the bullous pemphigoid disease activity index (BPDAI). Serum eosinophil counts, serum IgE levels, histopathology, and direct immunofluorescence (DIF) findings for IgE deposition at the basement membrane zone (BMZ) were analyzed.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Higher disease activity (BPDAI >20\/372) was observed in 77% of patients (27\/35). Fisher\u2019s exact test showed no significant association between higher BPDAI scores and elevated serum eosinophil counts (>500 cells\/\u00b5L), elevated serum IgE levels (>500 IU\/mL) or DIF-detected IgE deposition at BMZ. However, biopsy evidence of eosinophil-predominant inflammatory infiltrates was significantly associated with higher disease activity (odds ratio [OR] =9.638; 95% confidence interval [CI]: 1.613\u201356.952;\n P<\/jats:italic>\n = 0.029).\n <\/jats:p>\n <\/jats:sec>\n \n Limitations:<\/jats:title>\n Small sample size, cross-sectional analysis, biopsy site variability and immunofluorescence methodology may have limited detection of IgE-related associations. Sample size calculation was based on the expected prevalence of IgE reactivity, but the significant association identified in our study involved tissue eosinophilia, for which the study was not specifically powered.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Eosinophilic infiltration is strongly associated with BP severity, reinforcing its pathogenic role. Although serum IgE was frequently elevated, its correlation with severity was more evident when also detected in tissue.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/idoj.idoj_963_25","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:00:45Z","timestamp":1791468045000},"page":"816-821","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Correlation of Serum and Tissue Eosinophils and Immunoglobulin E with Disease Severity in Bullous Pemphigoid: A Prospective Observational Study"],"prefix":"10.4103","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6960-0332","authenticated-orcid":false,"given":"Kanimozhi","family":"Krishnamoorthy","sequence":"first","affiliation":[{"name":"Department of Dermatology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-703X","authenticated-orcid":false,"given":"Reena","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthisankari","family":"Shanmugasundaram","sequence":"additional","affiliation":[{"name":"Department of Pathology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","article-title":"The pathophysiology of bullous pemphigoid","volume":"33","author":"Kasperkiewicz","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.157.8.3642","article-title":"IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid","volume":"157","author":"Delaporte","year":"1996","journal-title":"J Immunol"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3389\/fimmu.2019.01974","article-title":"Serological diagnosis of autoimmune bullous skin diseases","volume":"10","author":"Saschenbrecker","year":"2019","journal-title":"Front Immunol"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","article-title":"Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: A useful clue for diagnosis","volume":"165","author":"Yayli","year":"2011","journal-title":"Br J Dermatol"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3389\/fimmu.2019.02331","article-title":"The intersection of IgE autoantibodies and eosinophilia in the pathogenesis of bullous pemphigoid","volume":"10","author":"Messingham","year":"2019","journal-title":"Front Immunol"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00403-017-1789-1","article-title":"IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: A systematic review","volume":"310","author":"Saniklidou","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12967-021-03192-8","article-title":"Bullous pemphigoid in diabetic patients treated by gliptins: The other side of the coin","volume":"19","author":"Chouchane","year":"2021","journal-title":"J Transl Med"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0190-9622(87)80227-X","article-title":"Blood eosinophilia as a severity marker for bullous pemphigoid","volume":"16","author":"Bernard","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/exd.13416","article-title":"Eosinophils as putative therapeutic targets in bullous pemphigoid","volume":"26","author":"Simon","year":"2017","journal-title":"Exp Dermatol"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"e2024169","DOI":"10.5826\/dpc.1403a169","article-title":"Frequency and correlation of peripheral and tissue eosinophilia with clinical manifestations in patients with bullous pemphigoid","volume":"14","author":"Abtahi-Naeini","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/jdv.17303","article-title":"The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid","volume":"35","author":"St\u00e4nder","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-20261030","first-page":"317","article-title":"Bullous pemphigoid in Liguria: A 2-year survey","volume":"15","author":"Cozzani","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20261030","first-page":"193","article-title":"Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin","volume":"18","author":"Provost","year":"1974","journal-title":"Clin Exp Immunol"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1523-1747.ep12283737","article-title":"Subclass distribution of IgG autoantibodies in bullous pemphigoid","volume":"86","author":"Bird","year":"1986","journal-title":"J Invest Dermatol"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/bjd.18364","article-title":"Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results","volume":"182","author":"Kamata","year":"2020","journal-title":"Br J Dermatol"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In vivo analysis of IgE autoantibodies in bullous pemphigoid: A study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J Dermatol Sci"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_963_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:05:47Z","timestamp":1793361947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_963_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_963_25","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"2025-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}